219 related articles for article (PubMed ID: 36184537)
1. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
4. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
Wu S; Feldman AS; Kim MM; Lin SX; Cornejo KM; Harisinghani MG; Dahl DM; Wu CL
Urology; 2023 May; 175():151-156. PubMed ID: 36828261
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.
Stabile A; Dell'Oglio P; Soligo M; De Cobelli F; Gandaglia G; Fossati N; Esposito A; Brembilla G; Karnes RJ; Montorsi F; Briganti A
Eur Urol Oncol; 2021 Aug; 4(4):594-600. PubMed ID: 31204312
[TBL] [Abstract][Full Text] [Related]
6. Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy.
De Luca S; Fiori C; Bollito E; Garrou D; Aimar R; Cattaneo G; De Cillis S; Manfredi M; Tota D; Federica M; Passera R; Porpiglia F
Minerva Urol Nefrol; 2020 Jun; 72(3):360-368. PubMed ID: 31619029
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
[TBL] [Abstract][Full Text] [Related]
8. Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy.
Kachanov M; Budäus L; Witt JH; Wagner C; Zinke J; Fangmeyer B; Schütte A; Spieker T; Beyersdorff D; Graefen M; Rachubinski P; Leyh-Bannurah SR
World J Urol; 2022 Dec; 40(12):2955-2961. PubMed ID: 36357604
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
Karsiyakali N; Ozgen MB; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
Urology; 2021 Feb; 148():217-223. PubMed ID: 32871139
[TBL] [Abstract][Full Text] [Related]
10. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.
Aslan G; Çelik S; Sözen S; Akdoğan B; İzol V; Yücel Bilen C; Sahin B; Türkeri L;
Int J Clin Pract; 2021 Mar; 75(3):e13797. PubMed ID: 33113261
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.
Kachanov M; Leyh-Bannurah SR; Roberts MJ; Sauer M; Beyersdorff D; Boiko S; Maurer T; Steuber T; Graefen M; Budäus L
J Urol; 2022 Feb; 207(2):333-340. PubMed ID: 34555925
[TBL] [Abstract][Full Text] [Related]
12. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
Sorce G; Stabile A; Pellegrino F; Mazzone E; Mattei A; Afferi L; Serni S; Minervini A; Roumiguiè M; Malavaud B; Valerio M; Rakauskas A; Marra G; Gontero P; Porpiglia F; Guo H; Zhuang J; Gandaglia G; Montorsi F; Briganti A
World J Urol; 2024 Apr; 42(1):248. PubMed ID: 38647689
[TBL] [Abstract][Full Text] [Related]
13. Detection of clinically significant prostate cancer by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in smaller prostates.
Dahl DM; Kim MM; Wu S; Lin SX; Crotty RK; Cornejo KM; Harisinghani MG; Feldman AS; Wu CL
Urol Oncol; 2022 Oct; 40(10):451.e9-451.e14. PubMed ID: 36008257
[TBL] [Abstract][Full Text] [Related]
14. The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.
Mannaerts CK; Kajtazovic A; Lodeizen OAP; Gayet M; Engelbrecht MRW; Jager GJ; Wijkstra H; de Reijke TM; Beerlage HP
Urol Oncol; 2019 May; 37(5):298.e1-298.e9. PubMed ID: 30660493
[TBL] [Abstract][Full Text] [Related]
15. Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study.
Porreca A; Del Giudice F; Giampaoli M; D'Agostino D; Romagnoli D; Corsi P; Del Rosso A; Maggi M; Chung BI; Ferro M; de Cobelli O; Lucarelli G; Schiavina R; De Berardinis E; Sciarra A; Busetto GM
Medicine (Baltimore); 2020 Sep; 99(37):e22059. PubMed ID: 32925739
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
[TBL] [Abstract][Full Text] [Related]
17. Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer.
Leyh-Bannurah SR; Kachanov M; Karakiewicz PI; Beyersdorff D; Pompe RS; Oh-Hohenhorst SJ; Fisch M; Maurer T; Graefen M; Budäus L
World J Urol; 2021 Jan; 39(1):81-88. PubMed ID: 32248363
[TBL] [Abstract][Full Text] [Related]
18. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
[TBL] [Abstract][Full Text] [Related]
19. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.
Goel S; Shoag JE; Gross MD; Al Hussein Al Awamlh B; Robinson B; Khani F; Baltich Nelson B; Margolis DJ; Hu JC
Eur Urol Oncol; 2020 Feb; 3(1):10-20. PubMed ID: 31492650
[TBL] [Abstract][Full Text] [Related]
20. The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and Multiparametric Magnetic Resonance Imaging (MRI)-targeted Biopsies are Discordant: Preliminary Findings Using Radical Prostatectomy Pathology as a Surrogate for MRI-targeted Biopsy Grade.
Scuderi S; Pellegrino F; Tin A; Beech BB; Gandaglia G; Stabile A; Eastham JA; Montorsi F; Briganti A; Vickers AJ
Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37739916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
